Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters









Database
Language
Publication year range
1.
Genetics and cardiovascular disease.
Loddo, I; Barbera, F; Di Gesaro, G; Cutrupi, M C; Calabrò, M P; Ceravolo, G; Salpietro, C; Gramaglia, S M C; Ceravolo, A; Concolino, D; De Sarro, R; Cuppari, C; Gitto, E; Clemenza, F; Di Carlo, D.
J Biol Regul Homeost Agents ; 34(4 Suppl. 2): 17-22. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY, 2020.
Article in English | MEDLINE | ID: mdl-33000595

Subject(s)
Cardiovascular Diseases , Cardiovascular Diseases/genetics , Genetic Predisposition to Disease , Humans , Risk Factors
2.
Congenital heart disease in Down Syndrome.
Gramaglia, S M C; Cuppari, C; Salpietro, C; Ceravolo, A; Cutrupi, M C; Concolino, D; De Sarro, R; Amatruda, M; Mondello, P; Ceravolo, G; Calabrò, M P; Gitto, E.
J Biol Regul Homeost Agents ; 34(4 Suppl. 2): 31-35. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY, 2020.
Article in English | MEDLINE | ID: mdl-33000597

Subject(s)
Down Syndrome , Heart Defects, Congenital , Down Syndrome/complications , Humans
3.
Pericarditis during infliximab therapy in paediatric ulcerative colitis.
Dipasquale, V; Gramaglia, S M C; Catena, M A; Romano, C.
J Clin Pharm Ther ; 43(1): 107-109, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28646522

ABSTRACT

WHAT IS KNOWN AND STUDY OBJECTIVE: Infliximab is a widely used drug for treating inflammatory bowel disease (IBD). This drug is known to rarely cause pericarditis in adult populations. CASE SUMMARY: This report details the case of a 14-year-old boy with ulcerative colitis who developed pericarditis after a second infliximab infusion. After discontinuation of therapy, the patient's symptoms were resolved. WHAT IS NEW AND CONCLUSION: To our knowledge, this is the first reported paediatric case of pericarditis as a possible complication of infliximab therapy in IBD. Among infliximab-related delayed adverse reactions, cardiac complications should be monitored in the paediatric population.


Subject(s)
Colitis, Ulcerative/drug therapy , Infliximab/adverse effects , Infliximab/therapeutic use , Pericarditis/chemically induced , Adolescent , Humans , Inflammatory Bowel Diseases/drug therapy , Male
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL